send link to app

Proveca Ireland Dosing App app for iPhone and iPad


4.0 ( 0 ratings )
Medical
Developer: Proveca Ltd
Free
Current version: 1.1.8, last update: 4 years ago
First release : 12 Dec 2019
App size: 0 Bytes

The Proveca dosing Calculator is CE marked as a class 1 medical device in compliance with medical device directive 93/42/EEC and is therefore considered acceptable by the HPRA in Ireland for its intended use.

This App and all of its content are the copyright of Proveca Limited. We grant you a non-exclusive licence to use the App subject to the following. You may use it solely for calculating dosages of Sialanar (providing you are a qualified medical professional) and accessing the additional data provided. We may terminate such licence at any time. You may not use the App or any of the contents for any other use and not to make any commercial gain. You must not do any of the following: copy (in whole or in part), disassemble, decompile or reverse engineer, rent, lease, sub-license, loan, translate, merge, adapt, vary or modify the software or its content in any way.
The Proveca digital dosing app has been designed to help clinicians find the most appropriate Sialanar dose for the patient. The dose is calculated by the patient’s weight or the dose the patient has been prescribed of the currently unlicensed glycopyrronium bromide. The app shows the doses in milligrams of glycopyrronium bromide and glycopyrronium, or millilitres of Sialanar. Extra information on the app includes the Summary of the Product Characteristics, Patient information leaflet, other product information, carer guidance, links to support groups for carers and patients, links to NICE guidelines, adverse event reporting and user guide.

Legal disclaimer: The calculator does not offer medical advice and is not intended as a substitute for informed medical advice. Its use should always be evaluated taking into consideration individual patient conditions. For max daily dosages please refer to the appropriate summary of product characteristics.